Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Endocrinology

Standard of Care Treatment and Hormone Replacement

At a Glance

Hypopituitarism treatment replaces the hormones your body lacks. When cortisol and thyroid hormones are both low, cortisol replacement is stabilized before thyroid treatment to prevent adrenal crisis, and hormone doses are monitored and adjusted individually.

Treatment for hypopituitarism is individualized. Because the pituitary gland is the master controller, your treatment involves replacing only the specific hormones your body can no longer produce [1]. This is called Hormone Replacement Therapy (HRT). The goal is to return your hormone levels to a physiological range to restore your energy, metabolism, and overall well-being [2].

Important: Never start, stop, or change your hormone replacement doses without explicit instructions from your prescribing team.

The Crucial Safety Rule: Adrenal First

If you have multiple hormone deficiencies, there is a vital safety rule: You must start glucocorticoid (cortisol) replacement before starting or increasing thyroid hormone replacement [3][4].

Thyroid hormone increases your body’s metabolic rate, which causes your body to process its available cortisol more quickly [5]. If your cortisol levels are already low and you start thyroid medication first, it can trigger a life-threatening adrenal crisis [6]. Your doctor will ensure your adrenal levels are stabilized first to keep you safe. (Note: In a true emergency, thyroid treatment need not be delayed if your adrenal function is adequate).

Managing the Adrenal Axis (ACTH)

If you have central adrenal insufficiency, replacing cortisol is critical.

  • The Medication: Most patients take hydrocortisone, usually divided into two or three doses per day to mimic the body’s natural rhythm [7][8]. Some doctors may use prednisolone [9].
  • Why No Fludrocortisone? Unlike primary adrenal failure (Addison’s disease), people with hypopituitarism do not usually need fludrocortisone [10]. This is because the adrenal glands’ ability to balance salt and blood pressure (via aldosterone) is regulated mainly by the renin-angiotensin system and potassium, rather than the pituitary, and therefore usually remains intact [11].
  • Sick-Day Management: You must follow a written plan to increase your dose during illness, fever, or major stress (the “stress dose”) [2]. Always carry a medical alert ID and an emergency hydrocortisone injection kit [12].

Managing the Thyroid Axis (TSH)

When the pituitary fails to produce TSH, your thyroid gland slows down.

  • The Medication: This is replaced with levothyroxine (L-T4) [3].
  • Monitoring: In standard hypothyroidism, doctors check TSH. In central hypothyroidism, TSH is not the primary dosing target [13]. Instead, your doctor will adjust your dose based on your Free T4 blood levels [14][15].

Managing Growth Hormone (GH)

Adult GH replacement is indicated only after appropriate confirmation of clinically significant deficiency and individualized risk-benefit assessment [16].

  • The Medication: Recombinant human GH is given via daily or weekly injection [17].
  • Personalized Dosing: Doses are highly individualized based on age, sex, and BMI [16].
  • Risks and Interactions: GH is contraindicated in active malignancy. It can cause swelling, joint pain, and headaches. Starting GH can lower your thyroid and cortisol levels further by changing how your body processes them [18]. If you start GH, your doctor should re-test your other hormone levels shortly after [19].

Managing the Reproductive and Fluid Axes

  • Sex Hormones: Men typically receive testosterone [16]. Women receive estrogen (and progesterone if they still have a uterus) [16]. If you wish to become pregnant or father a child, standard replacements will not work; you will need specialized treatment with gonadotropins and preconception planning [16].
  • Fluid Balance (Desmopressin): If you lack ADH (central diabetes insipidus), it is replaced with desmopressin (DDAVP) [1]. It helps your kidneys retain water. Safety Warning: Taking too much desmopressin or drinking excessive free water can cause dangerous dilutional hyponatremia. Follow your clinician’s fluid plan and seek urgent help for severe headaches, nausea, confusion, seizures, or marked drowsiness [10].

Common questions in this guide

Why does cortisol replacement usually come before thyroid hormone in hypopituitarism?
When both adrenal and thyroid hormone production are low, clinicians generally stabilize cortisol replacement before starting or increasing levothyroxine. Thyroid hormone can make the body use cortisol faster, so giving it while cortisol is deficient can trigger a life-threatening adrenal crisis. The order may differ in an emergency when adrenal function is known to be adequate.
How is levothyroxine dose monitored in central hypothyroidism?
TSH is not the main dosing target because pituitary TSH production is impaired. Clinicians use Free T4 blood levels, along with clinical assessment, to adjust levothyroxine. Do not change the dose without instructions from your prescribing team.
Do people with hypopituitarism usually need fludrocortisone?
People with central adrenal insufficiency from hypopituitarism usually do not need fludrocortisone because aldosterone and salt balance are mainly controlled by systems outside the pituitary. Hydrocortisone or another cortisol replacement medicine is used instead, and the prescribing clinician decides whether additional treatment is needed.
What should I do about hydrocortisone during illness?
Follow a written sick-day plan that explains how to increase hydrocortisone during fever, illness, or major stress. Carry medical alert identification and an emergency hydrocortisone injection kit if prescribed, and ask your clinician when urgent medical care or an injection is needed.
Can growth hormone change my other hormone replacement doses?
Yes. Growth hormone can lower thyroid and cortisol levels or change how the body processes them, so clinicians should recheck other hormone levels soon after starting it and adjust treatment if needed. Growth hormone is contraindicated in people with active malignancy.
What are the warning signs of too much desmopressin?
Too much desmopressin, especially with excessive free-water intake, can dilute the blood sodium level and cause hyponatremia. Severe headache, nausea, confusion, seizures, or marked drowsiness require urgent medical help.
Will testosterone or estrogen replacement restore fertility?
Standard testosterone or estrogen replacement does not restore fertility. People who want to become pregnant or father a child may need specialist treatment with gonadotropins and preconception planning.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on hypopituitarism.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Since I have both thyroid and adrenal deficiencies, can we confirm my hydrocortisone dose is stable before I start my first dose of levothyroxine?
  2. 2.Why is my TSH not a reliable marker for my thyroid replacement, and what specific 'Free T4' target number are we aiming for?
  3. 3.Do I need to carry an emergency hydrocortisone injection kit, and can you provide a written 'sick-day' protocol for when I get a fever or the flu?
  4. 4.If we decide to start Growth Hormone (GH) replacement, how will we adjust my other hormone doses, since GH can change how my body uses cortisol and thyroid medication?
  5. 5.How often will we check my sodium levels to make sure my desmopressin dose is correct and I'm not retaining too much fluid?

References

References (19)
  1. 1

    Hypopituitarism.

    Higham CE, Johannsson G, Shalet SM

    Lancet (London, England) 2016; (388(10058)):2403-2415 doi:10.1016/S0140-6736(16)30053-8.

    PMID: 27041067
  2. 2

    Adrenal insufficiency.

    Husebye ES, Pearce SH, Krone NP, Kämpe O

    Lancet (London, England) 2021; (397(10274)):613-629 doi:10.1016/S0140-6736(21)00136-7.

    PMID: 33484633
  3. 3

    Central Hypothyroidism: Advances in Etiology, Diagnostic Challenges, Therapeutic Targets, and Associated Risks.

    Iglesias P

    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2025; (31(5)):650-659 doi:10.1016/j.eprac.2025.02.004.

    PMID: 39947625
  4. 4

    Lessons of the month: A challenging presentation of hypopituitarism secondary to an intracerebral aneurysm.

    Mullarkey EM, Iyer A, Ihuoma A

    Clinical medicine (London, England) 2021; (21(2)):e228-e230 doi:10.7861/clinmed.2020-1017.

    PMID: 33762391
  5. 5

    Biochemical transition during triphasic postpartum thyroiditis: confusion with central hypothyroidism.

    Oyibo SO, Green OS, Laliwala NM, Sagi SV

    Endocrinology, diabetes & metabolism case reports 2021; (2021(21-0069)).

    PMID: 34280894
  6. 6

    Two Decades of Endocrine Silence: Severe Hyponatremia Presenting as Late-Onset Sheehan Syndrome.

    Sanjuanelo Fontalvo AJ, Clarete de la Rosa SM, Quintero Arrieta JF, et al.

    Cureus 2026; (18(7)):e113377 doi:10.7759/cureus.113377.

    PMID: 42643646
  7. 7

    Daily Glucocorticoid Replacement Dose in Adrenal Insufficiency, a Mini Review.

    Caetano CM, Malchoff CD

    Frontiers in endocrinology 2022; (13()):897211 doi:10.3389/fendo.2022.897211.

    PMID: 35846313
  8. 8

    Adrenal insufficiency - recognition and management.

    Pazderska A, Pearce SH

    Clinical medicine (London, England) 2017; (17(3)):258-262 doi:10.7861/clinmedicine.17-3-258.

    PMID: 28572228
  9. 9

    Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline.

    Bornstein SR, Allolio B, Arlt W, et al.

    The Journal of clinical endocrinology and metabolism 2016; (101(2)):364-89 doi:10.1210/jc.2015-1710.

    PMID: 26760044
  10. 10

    Central adrenal insufficiency: open issues regarding diagnosis and glucocorticoid treatment.

    Ceccato F, Scaroni C

    Clinical chemistry and laboratory medicine 2019; (57(8)):1125-1135.

    PMID: 30427776
  11. 11

    Factors impacting on the action of glucocorticoids in patients receiving glucocorticoid therapy.

    Dineen R, Stewart PM, Sherlock M

    Clinical endocrinology 2019; (90(1)):3-14 doi:10.1111/cen.13837.

    PMID: 30120786
  12. 12

    Adrenal Insufficiency in Adults: A Review.

    Vaidya A, Findling J, Bancos I

    JAMA 2025; (334(8)):714-725 doi:10.1001/jama.2025.5485.

    PMID: 40522647
  13. 13

    Interactions between hypothalamic pituitary thyroid axis and other pituitary dysfunctions.

    Feldt-Rasmussen U, Klose M, Benvenga S

    Endocrine 2018; (62(3)):519-527 doi:10.1007/s12020-018-1738-6.

    PMID: 30191443
  14. 14

    Median-lower normal levels of serum thyroxine are associated with low triiodothyronine levels and body temperature in patients with central hypothyroidism.

    Hirata Y, Fukuoka H, Iguchi G, et al.

    European journal of endocrinology 2015; (173(2)):247-56 doi:10.1530/EJE-15-0130.

    PMID: 25994949
  15. 15

    L-T4 Therapy in the Presence of Pharmacological Interferents.

    Benvenga S

    Frontiers in endocrinology 2020; (11()):607446 doi:10.3389/fendo.2020.607446.

    PMID: 33414765
  16. 16

    Management of Hypopituitarism.

    Alexandraki KI, Grossman A

    Journal of clinical medicine 2019; (8(12)) doi:10.3390/jcm8122153.

    PMID: 31817511
  17. 17

    AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF GROWTH HORMONE DEFICIENCY IN ADULTS AND PATIENTS TRANSITIONING FROM PEDIATRIC TO ADULT CARE.

    Yuen KCJ, Biller BMK, Radovick S, et al.

    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2019; (25(11)):1191-1232 doi:10.4158/GL-2019-0405.

    PMID: 31760824
  18. 18

    Treatment of the adult growth hormone deficiency syndrome with growth hormone: What are the implications for other hormone replacement therapies for hypopituitarism?

    Fierro G, Hoffman AR

    Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2020; (52()):101316 doi:10.1016/j.ghir.2020.101316.

    PMID: 32229369
  19. 19

    Effects of switching from somatropin to somapacitan on thyroid hormone levels in adult growth hormone deficiency: A pilot study.

    Tsujimoto Y, Yamashiro K, Suzuki Y, et al.

    Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2026; (85()):101720 doi:10.1016/j.ghir.2026.101720.

    PMID: 42335808

This page is for informational purposes only and does not constitute medical advice. Your endocrinology team must individualize hormone doses and guide emergency, sick-day, thyroid, growth hormone, and desmopressin decisions.